You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行报告》汇丰研究下调阿里健康(00241.HK)目标价至29元 评级「买入」
阿思达克 05-27 11:26
汇丰研究发表研报指,阿里健康(00241.HK)今年3月底止全年收入按年增长62%,较市场预测低约7%,净利润则较预测低22%,主要由於期内毛利率表现逊预期,按年持平在23.3%。

该行认为,主要由於期内处方药销售比例提高,产品组合调整导致利润增长较预期低。年度自营及第三方电商销售分别增长62%及68%,该行指出,阿里健康自营药店未来将专注於药物销售,预期慢性疾病药物将继续是公司主要增长动力。

考虑到阿里健康持续拓展与药企的合作,预期加大投资将令短期盈利能力提升,以及健康医疗料成未来发展趋势,汇丰研究维持对阿里健康的「买入」评级,目标价由33.5元降至29元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account